Key facts
- Notable investors include AgeTech Collaborative from AARP, Ian Desai, JanaLee Cherneski.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for ECHAS
- ·The full record, as it builds
Funding rounds
No funding rounds for ECHAS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ECHAS
Developer of a mobile health assessment platform intended for deciding when to seek urgent medical attention for cardiovascular events. The company offers an application that structures symptom input related to stroke and heart attack, applies rule based triage logic to categorize urgency, offers guidance on whether to call emergency services or contact a clinician, supports use by older adults and caregivers, and presents information in accessible language and interfaces, enabling consumers concerned about acute cardiovascular symptoms to perform preliminary self assessments, understand risk indications, and take timely next steps in engaging appropriate medical services based on structured decision support rather than unorganized or informal judgement.
- Sector
- Healthcare
- HQ
- Newton, MA, United States
- Founded
- 2021
- Website
- echas.com/
- Ownership
- Privately Held (backing)
ECHAS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ECHAS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ECHAS in its N-PORT filings yet. We sweep new filings monthly.